Role of the IGF-I receptor in the regulation of cell-cell adhesion: Implications in cancer development and progression

Journal of Cellular Physiology

Volumn 194, Issue 2, 2003, Pages 108-116

  Mauro, Loredana ^a,b   Salerno, Michele ^a,b   Morelli, Catia ^a,b   Boterberg, Tom ^c   Bracke, Marc E ^c   Surmacz, Eva ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CALABRIA   (Italy)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR; UVOMORULIN;

APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CANCER RESISTANCE; CARCINOGENESIS; CELL ADHESION; CELL GROWTH; CELL MATURATION; CELL SURVIVAL; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STIMULATION; TUMOR;

ANIMALS; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL PHYSIOLOGY; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASMS; RECEPTOR, IGF TYPE 1;

EID: 0037292936     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10207     Document Type: Review

References (115)

1. Aberle H, Schwartz H, Hemler R. 1996. Cadherin-catenin complex: Protein interactions and their implications for cadherin function. J Cell Biochem 61:514-523.
2. Adams JC. 1997. Cell adhesion-spreading frontiers, intricate insights. Trends Cell Biol 7:107-110.
3. Adams TI, Epa VC, Garrett TP, Ward CW. 2000. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57:1050-1093.
4. Andre F, Rigot V, Thimonier J, Montixi C, Parat F, Pommier G, Marvaldi J, Luis J. 1999. Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer 83:497-505.
5. Baserga R. 1999. The IGF-I receptor in cancer research. Exp Cell Res 253:1-6.
6. Baserga R. 2000. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19:5574-5581.
7. Behrens J. 1999. Cadherins and catenins: Role in signal transduction and tumor progression. Cancer Metastasis Rev 18:15-30.
8. Behrens J. 2000. Control of beta-catenin signaling in tumor development. Ann NY Acad Sci 910:21-33.
9. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. 1989. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108:2435-2447.
10. Berns EM, Klijn JGM, van Staveren IL, Portengen H, Foekens JA. 1992. Sporadic amplification of the IGF-I gene in human breast cancer. Cancer Res 52:1036-1039.
11. Berx G, Van Roy F. 2001. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 3:289-293.
12. Blakesley VA, Butler AA, Koval AP, Okubo Y, LeRoithg D. 1999. In: Rosenfeld RG, Roberts CT, Jr., editors. The IGF System. Totowa, NJ: Humana Press Inc. p 329-353.
13. Boggon TJ, Murray J, Chappuis-Flament S, Wong E, Gumbiner BM, Shapiro L. 2002. C-cadherin ectodomain structure and implications for cell adhesion mechanism. Science 296:1308-1313.
14. Bracke ME, Vyncke BM, Bruyneel EA, Vermeulen SJ, De Bruyne GK, Van Larebeke NA, Vleminckx K, Van Roy FM, Mareel MM. 1993. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 68:282-289.
15. Bracke ME, Depypere H, Labit C, Van Marck V, Vennekens K, Vermeulen SJ, Maelfait I, Philippe J, Serreyn R, Mareel MM. 1997. Functional downregulation of the E-cadherin/catenin complex leads to loss of contact inhibition of motility and of mitochondrial activity, but not of growth in confluent epithelial cell cultures. Eur J Cell Biol 74:342-349.
16. Bracke ME, Boterberg T, Mareel MM. 2001. Chick heart invasion assay. In: Brooks S, Schumacher U, editors. Metastasis Research Protocols. Vol. II. Analisis of Cell Behavior In Vitro and In Vivo. Totowa, NJ: Humana Press. p 91-102.
17. Bremnes RM, Veve R, Hirsch FR, Franklin WA. 2002. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36:115-124.
18. Burks DJ, White MF. 2001. IRS proteins and beta-cell function. Diabetes 50:S140-S145.
19. Burroughs KD, Howe SR, Okubo Y, Fuchs-Young R, LeRoith D, Walker CL. 2002. Dysregulation of IGF-I signaling in uterine leiomyoma. J Endocrinol 172:83-93.
20. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. 2002. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109:987-991.
21. Daniel JM, Reynolds AB. 1997. Tyrosine phosphorylation and cadherin/catenin function. BioEssay 19:883-891.
22. Deman JJ, Van Larebeke NA, Bruyneel EA, Bracke ME, Vermeulen SJ, Vennekens KM, Mareel MM. 1995. Removal of sialic acid from the surface of human MCF-7 mammary cancer cells abolished E-cadherin-dependent cell-cell adhesion in an aggregation assay. In Vitro Cell Dev Biol Anim 31:633-639.
23. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, Capeau J. 2001. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 20:252-259.
24. Djavan B, Waldert M, Seitz C, Marberger M. 2001. Insulin-like growth factors and prostate cancer. World J Urol 19:225-233.
25. Druckmann R, Rohr UD. 2002. IGF-1 in gynaecology and obstetrics: Update. 2002. Maturitas 41(Suppl 1):S65-S83.
26. Dupont J, Karas M, LeRoith D. 2000. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem 275:35893-35901.
27. Ferkey DM, Kimelman D. 2000. GSK-3: New thoughts on an old enzyme. Dev Biol 225:471-479.
28. Frixen UH, Beherens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W. 1991. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185.
29. Geiger B, Ayalon O. 1992. Cadherins. Ann Rev Cell Biol 8:307-333.
30. Giovannucci E. 2001. Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J Nutr 131(11 Suppl):3109S-3120S.
31. Gumbiner BM. 1996. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84:345-357.
32. Guvakova MA, Surmacz E. 1997. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival and promote cell-cell adhesion in human breast cancer cells. Exp Cell Res 231:149-162.
33. Hajra KM, Fearon ER. 2002. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34:255-268.
34. Hazan RB, Norton L. 1998. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 273:9078-9084.
35. Herrenknecht K, Ozawa M, Eckerskorn C, Lottspeich F, Lenter M, Kemler R. 1991. The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc Natl Acad Sci USA 88:9156-9160.
36. Hirohashi S. 2000. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers. Verh Dtsch Ges Pathol 84:28-32.
37. Hoover KB, Liao SY, Bryant PJ. 1998. Loss of the tight junction MAGUK ZO-1 in breast cancer: Relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 153:1767-1773.
38. Hoschuetzky H, Aberle H, Kemler R. 1994. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 127:1375-1380.
39. Hulsken J, Birchmeier W, Behrens J. 1994. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127:2061-2069.
40. Hursting SD, Perkins SN, Phang JM, Barrett JC. 2001. Diet and cancer prevention studies in p53-deficient mice. J Nutr 131: (11 Suppl):3092S-3094S.
41. Itoh M, Nagafuchi A, Moroi S, Tsukita SJ. 1997. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol 138:181-192.
42. Kandikonda S, Oda D, Niederman R, Sorkin BC. 1996. Cadherin-mediated adhesion is required for normal growth regulation of human gingival epithelial cells. Cell Adhes Commun 4:13-24.
43. Keirsebilck A, Van Hoorde L, Gao Y, De Bruyne G, Bruyneel E, Vermassen P, Mareel M, van Roy F. 1998. Mechanisms of down-regulation of transfected E-cadherin cDNA during formation of invasive tumors in syngeneic mice. Invasion Metastasis 18:44-56.
44. Kemler R. 1992. Classical cadherins. Semin Cell Biol 3:149-155.
45. Korc M. 1998. Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 7:25-41.
46. Le Roith D. 2000. Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor. Growth Horm IGF Res 10(Suppl A):S12-S13.
47. Lee AV, Yee D. 1995. Insulin-like growth factors and breast cancer. Biomed Pharmacother 49:415-421.
48. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in Vitro and in Vivo. Mol Endocrinol 13:787-796.
49. Li G, Satyamoorthy K, Herlyn M. 2001. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61:3819-3825.
50. Mareel M, Vleminckx K, Vermeulen S, Yan G, Bracke M, van Roy F. 1994. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer. Princess Takamatsu Symp 24:63-80.
51. Mareel M, Bracke M, Van Roy F. 1995. Cancer metastasis: Negative regulation by an invasion-suppressor complex. Cancer Detect Prev 19:451-464.
52. Mareel M, Berx G, Van Roy F, Bracke M. 1996. Cadherin/catenin complex: A target for antiinvasive therapy? J Cell Biochem 61:524-530.
53. Mareel M, Boterberg T, Noe V, Van Hoorde L, Vermeulen S, Bruyneel E, Bracke M. 1997. E-adherin/catenin/cytoskeleton complex: A regulator of cancer invasion. J Cell Physiol 173:271-274.
54. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M. 1992. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118:703-714.
55. Mauro L, Sisci D, Salerno M, Kim J, Tam T, Guvakova M, Ando S, Surmacz E. 1999. SHC-alpha5 beta1 integrin interactions regulate breast cancer cell adhesion and motility. Exp Cell Res 252:439-448.
56. Mauro L, Bartucci M, Morelli C, Ando S, Surmacz E. 2001. IGF-I receptor-induced cell-cell adhesion of MCF-7 breast cancer cells requires the expression of junction protein ZO-1. J Biol Chem 276:39892-39897.
57. Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T. 1996. E-cadherin expression in human breast cancer cells suppresses the development of osteolitic bone metastasis in an experimental metastasis model. Cancer Res 56:4063-4070.
58. Meiners S, Brinkmann V, Naundorf H, Birchmeier W. 1998. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16:9-20.
59. Muller T, Choidas A, Reichmann E, Ullrich A. 1999. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem 274:10173-10183.
60. Nagafuchi A, Takeichi M, Tsukita S. 1991. The 102 kd cadherin-associated protein: Similarity to vinculin and posttranscriptional regulation of expression. Cell 65:849-857.
61. Nicholson KM, Anderson N. 2002. The protein kinase B/Akt signaling in human malignancy. Cell Signal 14:381-395.
62. Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M. 2001. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res 61:6276-6280.
63. Noe V, Chastre E, Bruyneel E, Gespach C, Mareel M. 1999. Extracellular regulation of cancer invasion: The E-cadherin-catenin and other pathways. Biochem Soc Symp 65:43-62.
64. Novak A, Dedhar S. 1999. Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 56:523-537.
65. O'Connor R, Fennelly C, Krause D. 2000. Regulation of survival signals from the insulin-like growth factor-I receptor. Biochem Soc Trans 28:47-51.
66. Ochiai A, Akimoto S, Kanai Y, Shibata T, Oyama T, Hiroashi S. 1994. c-erbB-2 gene product associates with catenins in human cancer cells. Biochem Biophys Res Commun 205:73-78.
67. Ozawa M, Ringwald M, Kemler R. 1990. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 87:4246-4250.
68. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. 1998. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190-193.
69. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19:7203-7215.
70. Peruzzi F, Prisco M, Morrione A, Valentinis B, Baserga R. 2001. Antiapoptotic signaling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-raf and Nedd4. J Biol Chem 276:25990-25996.
71. Peyrat JP, Bonneterre J. 1992. Type 1 IGF receptor in human breast diseases. Breast Cancer Res Treat 22:59-67.
72. Playford MP, Bicknell D, Bodmer WF, Macaulay VM. 2000. Insulin-like growth factor 1 regulates the location, stability, and transcriptional of beta-catenin activity. Proc Natl Acad Sci USA 97:12103-12108.
73. Potter E, Bergwitz C, Brabant G. 1999. The cadherin-catenin system: Implications for growth and differentiation of endocrine tissues. Endocr Rev 20:207-239.
74. Prisco M, Peruzzi F, Belletti B, Baserga R. 2001. Regulation of Id gene expression by type I insulin-like growth factor: Roles of Stat3 and the tyrosine 950 residue of the receptor. Mol Cell Biol 21:5447-5458.
75. Provost E, Rimm DL. 1999. Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr Opin Cell Biol 11:567-572.
76. Railo MJ, Smitten K, Pekonen F. 1994. The prognostic value of insulin-like growth factor I in breast cancer. Results of a follow-up study on 126 patients. Eur J Cancer 30A:307-311.
77. Rajasekaran AK, Hojo M, Huima T, Rodriguez-Boulan EJ. 1996. Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. Cell Biol 132:451-463.
78. Reiss K, Wang JY, Romano G, Tu X, Peruzzi F, Baserga R. 2001. Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells. Oncogene 20:490-500.
79. Resnik JL, Reichart DB, Huey K, Webster NJG, Seely BL. 1998. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res 58:1159-1164.
80. Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJS, Phillips WA. 2001. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J Biol Chem 276:45113-45119.
81. Salerno M, Sisci D, Mauro L, Guvakova M, Ando S, Surmacz E. 1999. Insulin-receptor substrate 1 (IRS-1) is a substrate of a pure antiestrogen ICI 182,780. Int J Cancer 81:299-304.
82. Satyamoorthy K, Li G, Vaidya B, Patel D, Herlyn M. 2001. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res 61:7318-7324.
83. Scharf JG, Dombrowski F, Ramadori G. 2001. The IGF axis and hepatocarcinogenesis. Mol Pathol 54:138-144.
84. Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D. 2000. Downregulation of insulin-like growth factor I receptor and insulin receptor substrate 1 expression in advanced human breast cancer. Int J Cancer 89:506-513.
85. Shaw LM. 2001. Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol Cell Biol 21:5082-5093.
86. Shepherd PR, Withers D, Siddle K. 1998. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling. Biochem J 333:471-490.
87. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. 1996. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105:394-402.
88. Surmacz E. 2000. Function of the IGF-IR in breast cancer. J Mammary Gland Biol Neopl 5:95-105.
89. Surmacz E, Guvakova MA, Nolan MK, Nicosia RF, Sciacca L. 1998. Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat 47:255-267.
90. Symons JR, Levea CM, Mooney RA. 2002. Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes. Biochem J 365(Pt 2):513-519.
91. Takeichi M. 1990. Cadherins: A molecular family important in selective cell-cell adhesion. Annu Rev Biochem 59:237-252.
92. Takeichi M. 1991. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455.
93. Takeichi M. 1995. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7:619-627.
94. Tian YC, Phillips AO. 2002. Interaction between the transforming growth factor beta type II receptor/smad pathway and beta-catenin during transforming growth factor beta1-mediated adherens junction disassembly. Am J Pathol 160:1619-1628.
95. Tran NL, Adams DG, Vaillancourt RL, Heimark RL. 2002. Signaling from N-cadherin increases Bcl-2: Regulation of the phosphatidylinositol 3-Kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem 277:32905-32914.
96. Tsukita S, Furuse M, Itoh M. 1997. Molecular architecture of tight junctions: Occludin and ZO-1. Soc Gen Physiol Ser 52:69-76.
97. Valentinis B, Baserga R. 2001. IGF-I receptor signalling in transformation and differentiation. Mol Pathol 54:133-137.
98. Valentinis B, Reiss K, Baserga R. 1998. Insulin-like growth factor-I-mediated survival from anoikis: Role of cell aggregation and focal adhesion kinase. J Cell Physiol 176:648-657.
99. Van Aken E, De Wever O, Correia da Rocha AS, Mareel M. 2001. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439:725-751.
100. Vermeulen SJ, Bruyneel EA, van Roy FM, Mareel MM, Bracke ME. 1995. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. Br J Cancer 72:1447-1453.
101. Vuori K, Ruoslahti E. 1994. Association of insulin receptor substrate 1 with integrins. Science 266:1576-1576.
102. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG. 1996. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87:733-743.
103. Watabe-Uchida M, Uchida N, Imamura Y, Nagafuchi A, Fujimoto K, Uemura T, Vermeulen S, van Roy F, Adamson ED, Takeichi M. 1998. Alpha-Catenin-vinculin interaction functions to organize the apical junctional complex in epithelial cells. J Cell Biol 142:847-857.
104. Weiss EE, Kroemker M, Rudiger AH, Jockusch BM, Rudiger M. 1998. Vinculin is part of the cadherin-catenin junctional complex: Complex formation between alpha-catenin and vinculin. J Cell Biol 141:755-764.
105. Wheelock MJ, Soler AP, Kundsen KA. 2001. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 6:275-285.
106. White MF. 1998. The IRS-signalling system: A network of docking proteins that mediate insulin action. Mol Cell Biochem 182:3-11.
107. Willott E, Balda MS, Fanning AS, Jameson B, Van Itallie C, Anderson JM. 1993. The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junetions. Proc Natl Acad Sci USA 90:7834-7838.
108. Wu X, Yu H, Amos CI, Hong WK, Spitz MR. 2000. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst 92:737-743.
109. Yamada KM, Geiger B. 1997. Molecular interaction in cell adhesion complexes. Curr Opin Cell Biol 9:76-85.
110. Yamamoto T, Harada N, Kano K, Taya S, Canaani E, Matsuura Y, Mizoguchi A, Ide C, Kaibuchi KJ. 1997. The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol 139:785-795.
111. Yap AS, Niessen CM, Gumbiner BM. 1998. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J Cell Biol 141:779-789.
112. Yu JT, Foster RG, Dean DC. 2001. Transcriptional repression by RB-E2F and regulation of anchorage-independent survival. Mol Cell Biol 21:3325-3335.
113. Zong CS, Zeng L, Jiang Y, Sadowski HB, Wang LH. 1998. Stat3 plays an important role in oncogenic Ros- and insulin-like growth factor I receptor-induced anchorage-independent growth. J Biol Chem 273:28065-28072.
114. Zong CS, Chan J, Levy DE, Horvath C, Sadowski I-IB, Wang LH. 2000. Mechanism of STAT3 activation by insulin-like growth factor I receptor. J Biol Chem 275:15099-15105.
115. Zumkeller W, Schwab M. 1999. Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis: Potential diagnostic and therapeutic perspectives. Horm Metab Res 31:138-141.